Sandy has a portfolio of roles in the chemicals and biotechnology industry. Currently he is Chairman of both Synthace and Marine Biopolymers and a non-executive director of NiTech Solutions; in recent years he was Chairman of both Evolva and Warwick International and a non-executive director of Yule Catto (now Synthomer). He is a founding director of Cogency, a specialist advisor to private equity on chemical sector acquisitions; Cogency has worked on over 250 projects worth more than £10bn. Before setting up Cogency in 2001, he spent 25 years in the chemical industry, mostly in the Kelco Division of Merck (US), latterly as MD of its international business. Sandy is also involved in national activities; currently he is on the board of IBioIC, a new biotech Innovation Centre, IBLF, the UK’s Industrial Biotechnology Leadership Forum and SCDI’s Executive Committee. He was Chairman of Chemical Sciences Scotland, the strategic leadership body for this sector in Scotland for 8 years and has also been a member of various strategic bodies. He has a PhD in Chemistry and an Honorary DSc.